Weight loss and malnutrition despite adequate dietary intake has been reported to be part of the clinical course in advanced dementia of the Alzheimer type. We present a case of reversible weight loss associated with neuroleptic use in a patient with Alzheimer's disease and discuss a possible pathophysiological basis for the weight loss. (J Geriatr Psychiatry Neurol 1989-2:45-47).
Get full access to this article
View all access options for this article.
References
1.
Asplund K., Normark M., Petterson V.: Nutritional assessment of psychogeriatric patients. Age Ageing1981;10:87.
2.
Albiin N., Asplund K., Bjermer L.: Nutritional status of medical patients on emergency admission to hospital . Acta Med Scand1981;212:151.
3.
Sandman PO, Adolfson R., Nygren C., et al: Nutritional status and dietary intake in institutionalized patients with Alzheimer's disease and multi-infarct dementia. J Am Geriatr Soc1987;35:31.
4.
Bucht G., Adolfsson R., Lithner F., et al: Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. Acta Med Scand1983;213:387.
5.
Peabody CA, Warner MD, Whiteford HA, et al: Neuroleptics and the elderly. J Am Geriatr Soc1987;35:233.
6.
Marriott P., Pansa M., Hiep A.: Depot fluphenazine maintenance treatment and associated weight changes. Compr Psychiatry1981;22:320.
7.
Doss FW: The effect of antipsychotic drugs on body weight: A retrospective review. J Clin Psychiatry1979;40:528.
8.
Wise RA: Neuroleptic attenuation of intracranial self-stimulation: Reward or performance deficits. Life Sci1978;22:535.
9.
Wise RA: Catecholamine theories of reward: A critical review. Brain Res1978;152:215.
10.
Fouriezos G. , Hansson P., Wise RA: Neuroleptic-induced attenuation of brain stimulation reward in rats. J Comp Physiol Psychol1978;92:661-671.
11.
Fouriezos G. , Wise RA: Pimozide-induced extinction of intracranial self-stimulation: Response patterns rule out motor or performance deficits . Brain Res1976;103:377-380.
12.
Wise RA, Spindler J., deWit H., et al: Neuroleptic induced "anhedonia" in rats: Pimozide blocks reward quality of food. Science1978;210:262-264.
13.
Wise RA, Spindler J., Legault L.: Major attenuation of food reward with performance-sparing doses of pimozide in the rat. Can J Psychol1978;32:77-85.
14.
Alheid GF, Kelly J., McDermott LJ, et al: Supersensitivity to norephinephrine or dopamine antagonists after knife cuts that produce aphagia and adipsia in rats. Pharmacol Biochem Behav1977;6:647-657.
15.
Willis GL, Smith GC, Kinchington PC: Neuroleptic-like anorexia produced by an extra-cerebral DA antagonist. Brain Res Bull1983;11:21-24.
16.
McDuff T., Sumi SM: Subcortical degeneration in Alzheimer's disease. Neurology1985;35:123-126.
17.
Stief A.: Ulber die anatomischen Grundhlagen der vegetativen storungen bei Geisteskvankheifen . Dtsch Z Nervenhjeilk1927; 97:112-132.
18.
Divry P.: Des lesions de l'infundibulum dans la demence senile. J BelgNeurol Psychiatry1935;35:591-599.
19.
Greenwald BS , Marin DB, Silverman SM: Serotoninergic treatment of screaming and banging in dementia. Lancet1986;1: 1464-1465.
20.
Blundell JE : Serotonin and appetite. Neuropharmacology1984;23: 1537-1551.
21.
Gillberg C. : Low dopamine and serotonin levels in anorexia nervosa. Am J Psychiatry1983;140:948-949.
